Titel

Merkliste
1 Ergebnisse

Risk of severe COVID-19 outcomes associated with immune-med..:

MacKenna, Brian ; Kennedy, Nicholas A ; Mehrkar, Amir...
MacKenna , B , Kennedy , N A , Mehrkar , A , Rowan , A , Galloway , J , Matthewman , J , Mansfield , K E , Bechman , K , Yates , M , Brown , J , Schultze , A , Norton , S , Walker , A J , Morton , C E , Harrison , D , Bhaskaran , K , Rentsch , C T , Williamson , E , Croker , R , Bacon , S , Hickman , G , Ward , T , Davy , S , Green , A , Fisher , L , Hulme , W , Bates , C , Curtis , H J , Tazare , J , Eggo , R M , Evans , D , Inglesby , P , Cockburn , J , McDonald , H I , Tomlinson , L A , Mathur , R , Wong , A Y S , Forbes , H , Parry , J , Hester , F , Harper , S , Douglas , I J , Smeeth , L , Lees , C W , Evans , S J W , Goldacre , B , Smith , C H & Langan , S M 2022 , ' Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies : a nationwide cohort study in the OpenSAFELY platform ' , The Lancet Rheumatology , vol. 4 , no. 7 , pp. e490-e506 . https://doi.org/10.1016/S2665-9913(22)00098-4. , 2022

Link: https://kclpure.kcl.ac.uk/portal/en/publications/risk-..

RT Journal
T1 <Title>Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies:a nationwide cohort study in the OpenSAFELY platform</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftkingscollondon:oai:pure.atira.dk:publications_1a6021b6-8ec6-4785-9c8c-ecabc1bf8a99&Exemplar=1&LAN=DE
				
A1 MacKenna, Brian
A1 Kennedy, Nicholas A
A1 Mehrkar, Amir
A1 Rowan, Anna
A1 Galloway, James
A1 Matthewman, Julian
A1 Mansfield, Kathryn E
A1 Bechman, Katie
A1 Yates, Mark
A1 Brown, Jeremy
A1 Schultze, Anna
A1 Norton, Sam
A1 Walker, Alex J
A1 Morton, Caroline E
A1 Harrison, David
A1 Bhaskaran, Krishnan
A1 Rentsch, Christopher T
A1 Williamson, Elizabeth
A1 Croker, Richard
A1 Bacon, Seb
A1 Hickman, George
A1 Ward, Tom
A1 Davy, Simon
A1 Green, Amelia
A1 Fisher, Louis
A1 Hulme, William
A1 Bates, Chris
A1 Curtis, Helen J
A1 Tazare, John
A1 Eggo, Rosalind M
A1 Evans, David
A1 Inglesby, Peter
A1 Cockburn, Jonathan
A1 McDonald, Helen I
A1 Tomlinson, Laurie A
A1 Mathur, Rohini
A1 Wong, Angel Y.S
A1 Forbes, Harriet
A1 Parry, John
A1 Hester, Frank
A1 Harper, Sam
A1 Douglas, Ian J
A1 Smeeth, Liam
A1 Lees, Charlie W
A1 Evans, Stephen J.W
A1 Goldacre, Ben
A1 Smith, Catherine H
A1 Langan, Sinéad M
YR 2022
JF MacKenna , B , Kennedy , N A , Mehrkar , A , Rowan , A , Galloway , J , Matthewman , J , Mansfield , K E , Bechman , K , Yates , M , Brown , J , Schultze , A , Norton , S , Walker , A J , Morton , C E , Harrison , D , Bhaskaran , K , Rentsch , C T , Williamson , E , Croker , R , Bacon , S , Hickman , G , Ward , T , Davy , S , Green , A , Fisher , L , Hulme , W , Bates , C , Curtis , H J , Tazare , J , Eggo , R M , Evans , D , Inglesby , P , Cockburn , J , McDonald , H I , Tomlinson , L A , Mathur , R , Wong , A Y S , Forbes , H , Parry , J , Hester , F , Harper , S , Douglas , I J , Smeeth , L , Lees , C W , Evans , S J W , Goldacre , B , Smith , C H & Langan , S M 2022 , ' Risk of severe COVID-19 outcomes associated with immune-mediated inflammatory diseases and immune-modifying therapies : a nationwide cohort study in the OpenSAFELY platform ' , The Lancet Rheumatology , vol. 4 , no. 7 , pp. e490-e506 . https://doi.org/10.1016/S2665-9913(22)00098-4
LK http://dx.doi.org/https://kclpure.kcl.ac.uk/portal/en/publications/risk-of-severe-covid19-outcomes-associated-with-immunemediated-inflammatory-diseases-and-immunemodifying-therapies(1a6021b6-8ec6-4785-9c8c-ecabc1bf8a99).html
DO https://kclpure.kcl.ac.uk/portal/en/publications/risk-of-severe-covid19-outcomes-associated-with-immunemediated-inflammatory-diseases-and-immunemodifying-therapies(1a6021b6-8ec6-4785-9c8c-ecabc1bf8a99).html
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)